miRNA-27b Targets Vascular Endothelial Growth Factor C to Inhibit Tumor Progression and Angiogenesis in Colorectal Cancer

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Ye, Jun ^a,b   Wu, Xianguo ^a,b   Wu, Dang ^a,b   Wu, Pin ^a,b   Ni, Chao ^a,b   Zhang, Zhigang ^a,b   Chen, Zhigang ^a,b   Qiu, Fuming ^a,b   Xu, Jinghong ^a,b   Huang, Jian ^a,b  

^a China National Ministry of Education   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 27B; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, SCID; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84876074187     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060687     Document Type: Article

References (42)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Vo DM, Julien LA, Thorson AG, (2010) Current controversies in colon and rectal cancer. Minerva Chir 65: 677-693.
3. Greenlee RT, Hill-Harmon MB, Murray T, Thun M, (2001) Cancer statistics, 2001. CA Cancer J Clin 51: 15-36.
4. Mueller MM, Fusenig NE, (2004) Friends or foes- bipolar effects of the tumour stroma in cancer. Nature Reviews Cancer 4: 839-849.
5. Balkwill F, (2004) Cancer and the chemokine network. Nature Reviews Cancer 4: 540-550.
6. Cambien B, Richard-Fiardo P, Karimdjee BF, Martini V, Ferrua B, et al. (2011) CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRbeta in colorectal carcinoma. PLoS One 6: e28842.
7. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
9. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
10. Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, et al. (2010) miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 7: 694-707.
11. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, et al. (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17: 211-215.
12. Fang YX, Xue JL, Shen Q, Chen J, Tian L (2012) miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma. Hepatology.
13. Lee JJ, Drakaki A, Iliopoulos D, Struhl K (2011) MiR-27b targets PPARgamma to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells. Oncogene.
14. Urbich C, Kaluza D, Fromel T, Knau A, Bennewitz K, et al. (2011) MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood.
15. Biyashev D, Veliceasa D, Topczewski J, Topczewska JM, Mizgirev I, et al. (2011) MiR-27b controls venous specification and tip cell fate. Blood.
16. Van Trappen PO, Pepper MS, (2005) Lymphangiogenesis in human gynaecological cancers. Angiogenesis 8: 137-145.
17. Wissmann C, Detmar M, (2006) Pathways targeting tumor lymphangiogenesis. Clinical Cancer Research 12: 6865-6868.
18. Pepper MS, (2001) Lymphangiogenesis and tumor metastasis: myth or reality? Clinical Cancer Research 7: 462-468.
19. Kumar B, Chile SA, Ray KB, Reddy GE, Addepalli MK, et al. (2011) VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway. Angiogenesis 14: 371-380.
20. Dalerba P, Cho RW, Clarke MF, (2007) Cancer stem cells: models and concepts. Annu Rev Med 58: 267-284.
21. Bjerkvig R, Johansson M, Miletic H, Niclou SP, (2009) Cancer stem cells and angiogenesis. Semin Cancer Biol 19: 279-284.
22. Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer 8: 755-768.
23. Francipane MG, Alea MP, Lombardo Y, Todaro M, Medema JP, et al. (2008) Crucial role of interleukin-4 in the survival of colon cancer stem cells. Cancer Res 68: 4022-4025.
24. Korkaya H, Liu S, Wicha MS, (2011) Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest 121: 3804-3809.
25. Kawamoto H, Yuasa T, Kubota Y, Seita M, Sasamoto H, et al. (2010) Characteristics of CD133(+) human colon cancer SW620 cells. Cell Transplant 19: 857-864.
26. Robison AJ, Nestler EJ, (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12: 623-637.
27. Lujambio A, Esteller M, (2007) CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 6: 1455-1459.
28. Wee EJ, Peters K, Nair SS, Hulf T, Stein S, et al. (2012) Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer. Oncogene.
29. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, et al. (2010) Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 31: 2066-2073.
30. Khromova N, Kopnin P, Rybko V, Kopnin BP, (2012) Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms. Oncogene 31: 1389-1397.
31. Gore AV, Swift MR, Cha YR, Lo B, McKinney MC, et al. (2011) Rspo1/Wnt signaling promotes angiogenesis via Vegfc/Vegfr3. Development 138: 4875-4886.
32. Ji J, Shi J, Budhu A, Yu Z, Forgues M, et al. (2009) MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361: 1437-1447.
33. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
34. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19: 232-243.
35. Liston A, Linterman M, Lu LF, (2010) MicroRNA in the adaptive immune system, in sickness and in health. J Clin Immunol 30: 339-346.
36. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
37. Zhao Y, Bao Q, Renner A, Camaj P, Eichhorn M, et al. (2011) Cancer stem cells and angiogenesis. Int J Dev Biol 55: 477-482.
38. Faivre S, Demetri G, Sargent W, Raymond E, (2007) Molecular basis for sunitinib efficacy and future clinical development. Nat Rev Drug Discov 6: 734-745.
39. Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, et al. (2010) High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 59: 953-962.
40. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, et al. (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82.
41. Borel F, Konstantinova P, Jansen PL (2012) Diagnostic and Therapeutic Potential of miRNA Signatures in Patients with Hepatocellular Carcinoma. J Hepatol.
42. Trang P, Weidhaas JB, Slack FJ, (2008) MicroRNAs as potential cancer therapeutics. Oncogene 27Suppl 2: S52-57.